1. Fig. 3. H3N2 incidence forecasts based on the cluster model for the Unites States.
H3N2 incidence forecasts based on the cluster model for the Unites States. (A) Monthly forecasts and (B) predictions versus observations of seasonal incidence totals. The different colors in both panels correspond to the following: leave-one-out cross-validation (for each influenza season from 2003/2004 to 2010/2011; in blue), retrospective forecasts (for each out-of-fit influenza season from 2011/2012 to 2015/2016; in red), and a real-time forecast for the 2016/2017 influenza season (in green). These predictions for cross-validations are simulated on a seasonal basis from estimated initial conditions starting in June and based on parameters estimated with all the data in the training data set with the target season excluded. The forecasts for the out-of-fit period are also simulated on a seasonal basis from estimated initial conditions starting in June but are based on parameters estimated with all the data up to that point in time. The average monthly H1N1 incidence from this training data set was used for forecasting purposes because the observation of this driver quantity would not be available. Similarly, the quantities specifying the evolutionary change of the virus were extrapolated as the sequences required for their computation would not be available (see Materials and Methods). The black curve is the monthly observed H3N2 incidence; the colored curve is the predicted monthly median incidence with shaded 95% uncertainty intervals (2.5 and 97.5% quantiles) from 1000 random simulations with the best models. The seasonal incidence is the sum of the monthly incidence for a specific influenza season. The observed incidence data for the 2016/2017 influenza season, which were not yet available when this study was conducted, are shown with the dotted line (and based on data from the weekly U.S. influenza surveillance report until week 14 ending on 8 April 2017). There is a significant correlation (P < 0.05) between observed incidence and median incidence, from the cross-validation forecasts for both monthly data (r = 0.66 and r2 = 0.44) and seasonal data (r = 0.88 and r2 = 0.77) and from both the retrospective and real forecasts (r = 0.81 and r2 = 0.67 for monthly data, fig. S4; r = 0.90 and r2 = 0.81 for seasonal data; Pearson’s product moment correlations).
Xiangjun Du et al., Sci Transl Med 2017;9:eaan5325
Published by AAAS